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Abstract: A series of 24 derivatives of tetrahydroquinazolinone has been syn-
thesized by the one-pot cyclocondensation reaction of N-allyl quinolones, 
cyclic  β-diketones and (thio)urea/N-phenylthiourea in the presence of lan-
thanum triflate catalyst. This methodology allowed the products to be achieved 
in excellent yield by stirring at room temperature. All the synthesized com-
pounds were investigated against a representative panel of pathogenic strains 
using the broth microdilution MIC (minimum inhibitory concentration) method 
for their in vitro antimicrobial activity. Amongst these sets of heterocyclic 
compounds 5h, 6b, 6h, 5f, 5l, 5n and 6g were found to have admirable activity. 
Keywords: quinolone; Biginelli reaction; one-pot synthesis; catalyst; antimic-
robial activity. 
INTRODUCTION 
Quinazolinones possess diverse pharmacological and biological activities as-
sociated with the pyrimidine core, such as hypotensive,1 analgesic and anti-in-
flammatory,2 calcium antagonist3 and central nervous system (CNS) depressant.4 
Furthermore, quinazolinones were found to exhibit antimicrobial activity against 
Staphylococcus aureus, Escherichia coli and Candida albicans.5 Therefore, the 
synthesis of quinazolinone derivatives still attract much attention of modern-day 
medicinal chemistry research. On other hand, quinolones have maintained their 
pharmacological importance since their discovery based on nalidixic acid in the 
early 1960s.6 Quinolones possess various biological activities, such as anti-HIV,7 
antitumor,8 anti-anaerobe9 and antimicrobial.10 It is well established that hydro-
phobicity is one of the factors that directly correlates to antimicrobial activity and 
intensifies the potency of a molecule.11,12 In view of this, an allyl group was in-
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serted at the N of quinolone ring to increase the hydrophobicity of the com-
pounds. Thus, based on the above reports, an attempt was undertaken to syn-
thesize  N-allylquinolone-incorporated quinazolinone derivatives based on the 
premise that allylic compounds have an additive effect to antimicrobial potency 
and the amalgamation of two bioactive moieties into a single scaffold may pro-
duce novel heterocycles with appealing antimicrobial activities.  
Tetrahydroquinazolinone derivatives have been synthesized under Biginelli 
reaction conditions (protic acid) but these methods suffer from low to moderate 
yields, lengthy reaction time and harsh reaction conditions.13 It was found that 
not only protic, but also Lewis acids could be used as a catalyst for the synthesis 
of tetrahydroquinazolinone derivatives.14 More recently, a number of reports ex-
pressing the utility of triflates as a Lewis acid catalyst in Biginelli protocols to 
give excellent yields, shorter reaction time and mild reaction conditions were 
published.15 
From the aforementioned facts and as a part of ongoing studies in the deve-
lopment of new antimicrobial agents containing various heterocyclic systems 
having a quinoline nucleus,16 N-allylquinolone-incorporated tetrahydroquinazo-
linone derivatives 5a–p and 6a–h were prepared via a multiple component con-
densation (MCC) approach using lanthanum triflate (La(OTf)3) as the catalyst 
and the results are reported herein. The constitution of all the products was cha-
racterized using elemental analysis, and FT-IR, 1H-NMR, 13C-NMR and mass 
spectrometry. The synthesized compounds were subjected to an in vitro antimic-
robial study against a representative panel of seven human pathogens using the 
broth microdilution minimum inhibitory concentration (MIC) method.17 
RESULTS AND DISCUSSION 
Chemistry 
In this protocol, 1-allyl-2-oxo-1,2-dihydroquinoline-3-carbaldehydes  1a–d 
were selected as model compounds for the one-pot syntheses to give heterocyclic 
systems with a quinazolinone core. The key intermediates 1a–d were prepared by 
electrophile-favored N-alkylation of 2-oxo-1,2-dihydroquinoline-3-carbaldehydes 
in presence of K2CO3 in DMF at room temperature.18 
All the 4-(1-allyl-2-oxo-1,2-dihydroquinolin-3-yl)-4,6,7,8-tetrahydroquina-
zoline-2,5(1H,3H)-dione derivatives 5a–p and 6a–h were obtained by La(OTf)3 
catalyzed reaction19–21 of various 1-allyl-2-oxo-1,2-dihydroquinoline-3-carbal-
dehydes 1a–d, cyclohexane-1,3-dione or dimedones 2a–b and (thio)ureas 3a–b 
or N-phenylthiourea 4 in ethanol at room temperature (Scheme 1). The reaction 
was examined by taking different mol ratios of catalyst, i.e., 2.5, 5, 7.5, 10 and 
12.5 mol %. It was observed that when the amount of La(OTf)3 was increased to 
10 mol %, the reaction rate accelerated within 1.5–2 h for 5a–p and 3–3.5 h for 
6a–h with high conversion, but the further increase in the amount of La(OTf)3 
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had no significant outcome on the reaction. The products were obtained in ex-
cellent yield at room temperature in ethanol only by use of 10 mol % catalyst; 
thus, these conditions were considered as the most optimized conditions for the 
synthesis of the title quinazolinone derivatives 5a–p and 6a–h. 
 
Scheme 1. Synthetic pathway to compounds 1a–d, 5a–p and 6a–h. 
The formation of compounds 5a–p and 6a–h may proceed via two steps 
(Scheme 2): i) the formation of arylidene(thio)urea Int-1 and ii) interception of 
the acyliminium ion intermediate by an activated cyclic β-diketone to produce an 
open chain urea Int-2, which subsequently undergoes cyclization and dehydra-
tion via Int-3 to afford the corresponding quinazolinone. The formation of an 
acyliminium ion was reported to be the rate-determining step.20 La(OTf)3 is 
thought to accelerate the formation of the arylidene(thio)urea Int-1 and activate 
the cyclic β-diketone  2a–b by forming its metal enolate, thus facilitating the 
addition reaction with a coordinated acyliminium ion.21 
The identities of all the synthesized compounds 5a–p and 6a–h were deter-
mined from 1H-NMR, 13C-NMR and FT-IR spectral data and elemental analysis. 
As an example, 1H-NMR (DMSO-d6) spectrum of 5a, exhibited singlet peaks at 
δ 9.52 and 7.80 ppm for the (–NH–) protons of the quinazolinone ring. A doublet 
was observed at around δ 4.90–5.05 ppm for (N–CH2–CH=CH2). Another doub-
let appeared at δ 5.18 ppm for (N–CH2–CH). Multiplets were observed at δ 5.94 
and around 7.08–7.60 ppm for (CH=CH2) and aromatic protons, respectively. 
The methine proton at C4 of quinazolinone appeared at δ 5.36 ppm as a singlet. A 
multiplet appeared at around δ 1.97–2.54 ppm for 3CH2. The 13C-NMR spec-
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trum is in agreement with the assigned structure. Thus, in the 13C-NMR spectrum 
of compound 5a, the signals around δ 105.51–152.04 ppm are attributed to aro-
matic carbons and the allylic C=C. The signals at around δ 21.28–36.80 ppm and 
at δ 49.39 ppm arise from aliphatic carbons and the allylic methylene carbon, 
respectively. In addition, the signal observed at δ 49.31 ppm is due to C4 of 
quinazolinone. The signals due to carbonyl carbons appeared at δ 156.69, 160.72 
and 193.67. The IR spectrum of 5a exhibited absorption bands at 3435 and 3352 
cm–1 for N–H str. and at 1711, 1639, and 1593 cm–1 for C=O str. The structure 
of compound 5a was also confirmed by mass spectral studies. It gave a molecular 
ion peak at m/z 350.2 [M+1]+, corresponding to the molecular formula C20H19N3O3. 
The obtained elemental analysis data are in consonance with the theoretical values.  
 
Scheme 2. Believable mechanistic pathway for the formation of compounds 5a–p and 6a–h 
by La(OTf)3 catalysis. 
The analytical and spectroscopic characterization data of 5a–p and 6a–h are 
given in the Supplementary material to this paper. 
Antimicrobial evaluation 
The antibacterial screening data (Table I) revealed that compound 5h (MIC =  
= 20 µg mL–1) had extraordinary antibacterial activity against Pseudomonas 
aeruginosa when compared with chloramphenicol and ciproﬂoxacin. Against Es-
cherichia coli, compounds 6b and 6h (MIC = 50 µg mL–1) were found to have 
outstanding antibacterial activity when compared with ampicillin and were equi-
potent to chloramphenicol, while compounds 5l and 5n (MIC = 62.5 µg mL–1) 
were found to have better activity than ampicillin. Against Staphylococcus au-
reus, compounds 5f and 6g (MIC = 62.5 µg mL–1) were found to have excellent 
activity; compounds 5e and 5p (MIC = 100 µg mL–1), as well as 5d, 5g and 6e 
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(MIC = 125 µg mL–1) showed remarkable results, while compounds 5i, 5k, 5m 
and 6h (MIC = 200 µg mL–1) exhibited good activity; compounds 5a, 5c, 5h, 5j 
and 6f (MIC = 250 µg mL–1) were found to be equally potent to ampicillin. 
Against Streptococcus pyogenes, compounds 5e, 5g, 5m, 5p and 6e (MIC = 100 
µg mL–1) were found to have comparable activity to that of ampicillin. Against 
E. coli, compounds 5j, 5k, 5m and 6f (MIC = 100 µg mL–1) were equipotent to 
ampicillin. 
TABLE I. Antimicrobial activity (MIC / μg mL-1) of compounds 5a–p and 6a–h 
Compounds 
Gram-positive 
bacteria 
Gram-negative 
bacteria  Fungi 
S. 
aureus
S. 
pyogenes
E. 
coli 
P. 
aeruginosa
C. 
albicans
A. 
niger 
A. 
clavatus 
MTCC
96 
MTCC 
442 
MTCC
443 
MTCC 
1688 
MTCC 
227 
MTCC 
282 
MTCC 
1323 
5a (R1=H, R2=R3=H, X=O)  250  250  125  200  500  1000  1000 
5b (R1=H, R2=R3=CH3, 
X=O) 
500 500 200  250  1000 500  500 
5c (R1=H, R2=R3=H, X=S)  250  500  250  250  1000  >1000  >1000 
5d (R1=H, R2=R3=CH3, 
X=S) 
125 200 200  200  >1000  >1000  >1000 
5e (R1=CH3, R2=R3=H, 
X=O) 
100 100 125  125  500 250  500 
5f (R1=CH3, R2=R3=CH3, 
X=O) 
62.5 125 500  250  500 1000  1000 
5g (R1=CH3, R2=R3=H, 
X=S) 
125 100 250  250  250 500  1000 
5h (R1=CH3, R2=R3=CH3, 
X=S) 
250 250 250  20  250 1000  500 
5i (R1=OCH3, R2=R3=H, 
X=O) 
200 250 125  200  1000 500  500 
5j (R1=OCH3, R2=R3=CH3, 
X=O) 
250 250 100  125  >1000  >1000  >1000 
5k (R1=OCH3, R2=R3=H, 
X=S) 
200 200 100  200  >1000  >1000  >1000 
5l (R1=OCH3, R2=R3=CH3, 
X=S) 
500 500  62.5  100  500 250  500 
5m (R1=Cl, R2=R3=H, 
X=O) 
200 100 100  200  1000  >1000  >1000 
5n (R1=Cl, R2=R3=CH3, 
X=O) 
500 200  62.5  125  >1000  >1000  >1000 
5o (R1=Cl, R2=R3=H, X=S)  500  250  250  250  >1000  >1000  >1000 
5p (R1=Cl, R2=R3=CH3, 
X=S) 
100 100 200  200  500 250  500 
6a (R1=H, R2=R3=H) 500  250  125  100  1000  >1000  >1000 
6b (R1=H, R2=R3=CH3) 500  500 50  125  200  500  500 
6c (R1=CH3, R2=R3=H) 500  500  200 250  500  1000  1000 
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TABLE I. Continued 
Compounds 
Gram-positive 
bacteria 
Gram-negative 
bacteria  Fungi 
S. 
aureus
S. 
pyogenes
E. 
coli 
P. 
aeruginosa
C. 
albicans
A. 
niger 
A. 
clavatus 
MTCC
96 
MTCC 
442 
MTCC
443 
MTCC 
1688 
MTCC 
227 
MTCC 
282 
MTCC 
1323 
6d (R1=CH3, R2=R3=CH3) 500  500  200  250  1000  500  500 
6e (R1=OCH3, R2=R3=H) 125  100  250  250  1000 500 500 
6f (R1=OCH3, R2=R3=CH3) 250  200  100  100  500  1000  1000 
6g (R1=Cl, R2=R3=H) 62.5  200  500  250 500  500  100 
6h (R1=Cl, R2=R3=CH3) 200 250 50  100  250 100  250 
Ampicillin 250  100  100  –  –  –  – 
Chloramphenicol 50  50  50  50  –  –  – 
Ciprofloxacin 50  50  25  25  –  –  – 
Nystatin –  –  –  –  100  100  100 
Griseofulvin –  –  –  –  500  100  100 
The antifungal screening data (Table I) revealed that compounds 6b (MIC =  
= 200 µg mL–1), 5g, 5h and 6h (MIC = 100 µg mL–1) were found to have ex-
cellent activity against Candida albicans, while compounds 5a, 5e, 5f, 5l, 5p, 6c, 
6f and 6g (MIC = 500 µg mL–1) had comparable activity to that of griseofulvin. 
Compounds 6h and 6g (MIC = 100 µg mL–1) were found to be equally potent 
against Aspergillus niger and A. clavatus, respectively. 
The newly synthesized compounds 5a–p and 6a–h exerted significant inhi-
bitory activity against the growth of the tested bacterial and fungal strains. The 
data also revealed that insertion of an allyl chain at the N of the quinolone moiety 
and derivatization at positions R1, R2, R3, X and N-1 of tetrahydroquinazolinone 
produced marked changes in the potency of the synthesized analogues as anti-
microbial agents and demonstrated the following assumptions about the struc-
ture–activity relationship (SAR): 
Compounds having a –CH3 substituent at the R2 and R3 positions have 
intensified antibacterial effectiveness against Gram negative bacteria, e.g., 5h, 5l, 
5n, 6b and 6h, but not 5f. Moreover, an S-atom at the C2 position and a phenyl 
group at N-1 of tetrahydroquinazolinone may play a significant role in enhancing 
antifungal activity, e.g., 5h, 5l, 6b, 6h and 6g. However, only phenyl substituted 
compounds displayed similar inhibitory action against the Aspergillus  family 
when compared with standard drugs. Compounds with electron withdrawing 
group –Cl at R1 of the N-allylquinolone ring may have improved activity against 
E. coli, S. aureus and all fungal species, e.g., 5m, 5n, 6g and 6h. On the other 
hand, the electron donating –OCH3 group may increase the activity against E. 
coli and S. aureus, e.g., 5j, 5k, 5l and 6f. A lipophilic –CH3 group at the R1 posi-
tion may intensify the potency against P. aeruginosa, S. aureus and C. albicans. 
_____________________________________________________________________________________________________________________
2012 Copyright (CC) SCS
Available online at www.shd.org.rs/JSCS/ TETRAHYDROQUINAZOLINONES  OF  N-ALLYL QUINOLONE AS ANTIMICROBIALS  1567 
Furthermore, the allyl chain makes the compounds more hydrophobic and may 
enhance the antimicrobial potency of the title compounds. The study revealed that 
changes in substitutions have a vast impact on the antimicrobial effectiveness.  
Upon comparison with a previous report,16b it could be stated that i) in-
sertion of an allyl group at N of the quinolone ring increases the antimicrobial 
properties of the title compounds; ii) both electron withdrawing and donating 
constituents at the R1 position contribute to enhancement of the antimicrobial 
effectiveness; iii) a phenyl group at N-1 of the tetrahydroquinazolinone ring in-
fluences the microbial inhibitory action and iv) the lipophilic –CH3 group at the 
R1 position has an additive effect on the inhibition of microbial pathogens. 
EXPERIMENTAL 
Materials, instruments and methods 
All the reagents were commercially available and used without further purification. Sol-
vents of analytical grade were used. Melting points were determined by the open tube ca-
pillary method (using silicon oil 350 cSt) and are uncorrected. Thin-layer chromatography 
(TLC, on aluminum plates pre-coated with silica gel, 60F254, 0.25mm thickness) (Merck, 
Darmstadt, Germany) was used for monitoring the progress of all reactions, as well as the 
purity and homogeneity of the synthesized compounds; eluent n-hexane:ethyl acetate 1:1. UV 
radiation and/or iodine were used as the visualizing agents. Elemental analysis (% C, H, N) 
was realized using a Perkin-Elmer 2400 series-II elemental analyzer (Perkin-Elmer, USA) and 
the results for all compounds were within ±0.4 % of the theoretical value. The IR spectra were 
recorded in KBr on a Perkin-Elmer Spectrum GX FT-IR Spectrophotometer (Perkin-Elmer, 
USA) and only the characteristic peaks are reported in cm-1. 1H-NMR and 13C-NMR spectra 
were recorded in DMSO-d6 on a Bruker Avance 400F (MHz) spectrometer (Bruker Scientific 
Corporation Ltd., Switzerland) at 400 and 100 MHz, respectively, using the solvent peak as an 
internal standard. Chemical shifts are reported in parts per million (ppm). Mass spectra were 
scanned on a Shimadzu LCMS 2010 spectrometer (Shimadzu, Tokyo, Japan). 
General procedure for the synthesis of 4-(1-allyl-2-oxo-1,2-dihydroquinolin-3-yl)-4,6,7,8-tetra-
hydroquinazolin-2,5(1H,3H)-diones 5a–p and 6a–h 
A 100 mL round bottomed flask, was charged with a mixture of 1-allyl-6-(un)substi-
tuted-2-oxo-1,2-dihydroquinoline-3-carbaldehydes 1a–d (3 mmol), cyclohexane-1,3-dione or 
dimedone 2a–b (3 mmol) and (thio)urea 3a–b/N-phenylthiourea 4 (3 mmol) in ethanol (15 
mL) containing La(OTf)3 (10 mol %). The mixture was allowed to stir at rt for 1.5–3.5 hr and 
the progress of the reaction was monitored by TLC. After the completion of reaction (as evi-
denced by TLC), the solid mass separated was collected by filtration, washed well with etha-
nol (15 mL) and purified by leaching in equal volume ratio of chloroform and methanol (20 
mL) to obtain pure solid sample.  
Methodology for screening the antimicrobial activity 
All the glass apparatus were sterilized before use. The antimicrobial activity of all the 
synthesized compounds was screened by the broth microdilution method.17 Mueller–Hinton 
broth was used as the nutrient medium to grow and dilute the compound suspension for the 
test bacteria and Sabouraud dextrose broth was used for fungal nutrition. Inoculum size for 
test strain was adjusted to 108 CFU ml-1 (colony forming unit per milliliter) by comparing the 
turbidity (turbidimetric method). The strains used for the activity were obtained from Mic-
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robial Type Culture Collection (MTCC) of the Institute of Microbial Technology, Chandigarh, 
India. Each synthesized compound was diluted to a concentration of 2000 µg mL-1, as a stock 
solution. DMSO was used as the vehicle to obtain the desired concentrations of the com-
pounds to test upon microbial strains. The results were recorded in the form of primary and 
secondary screenings. The compounds 5a–p and 6a–h were screened for their antibacterial 
activity against the Gram-positive bacteria: S. aureus (MTCC 96) and S pyogenes (MTCC 
442), and Gram-negative bacteria: E. coli (MTCC 443) and P. aeruginosa (MTCC 1688), and 
antifungal activity against the fungi: C. albicans (MTCC 227), A. niger (MTCC 282) and A. 
clavatus (MTCC 1323) at concentrations of 1000, 500, and 250 µg mL-1 as primary screening. 
Compounds that were found to be active in the primary screening were further screened in a 
second set of dilution at concentrations of 200, 100, 62.5, 50, 25, 12.5, and 6.25 µg mL-1. Ten 
microliters suspension from each well was further inoculated and growth of the bacteria and 
fungi was noted after 24 and 48 h, respectively. The lowest concentration which resulted in no 
visible growth (turbidity) after spot subculture was considered as the MIC for each compound. 
The standard drugs used for comparison in this study were ampicillin, chloramphenicol and 
ciproﬂoxacin for evaluating the antibacterial activity and griseofulvin and nystatin for the 
antifungal activity. 
CONCLUSIONS 
In present protocol, the synthesis and antimicrobial evaluation of 24 new 
derivatives 5a–p and 6a–h of tetrahydroquinazolinone possessing an N-allylqui-
nolone nucleus at C4 of quinazolinone were presented. La(OTf)3 as catalyst al-
lowed the smooth synthesis of the title derivatives at room temperature in ex-
cellent yield. It could be concluded from the antimicrobial screening data that 
many of the compounds were more or equipotent against a panel of human pa-
thogens when compared with the standard drugs. It is noteworthy that derivati-
zation of the title compounds alter their antimicrobial activity. Further synthetic 
work to intensify the potency of these derivatives by changing their molecular 
configuration is in progress. The present study highlights the identification of this 
new structural class of compounds as antimicrobials, which could be of interest 
for further detailed pre-clinical investigations. 
SUPPLEMENTARY MATERIAL 
Analytical and spectroscopic characterization data of the compounds 5a–p and 6a–h are 
available electronically from http://www.shd.org.rs/JSCS/, or from the corresponding author 
on request. 
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ИЗВОД 
СИНТЕЗА ТЕТРАХИДРОХИНАЗОЛИНОНСКИХ ДЕРИВАТА N-AЛИЛХИНОЛОНА 
ПОМОЋУ ЛАНТАН-ТРИФЛАТА И ОДРЕЂИВАЊЕ ЊИХОВЕ БИОЛОШКЕ АКТИВНОСТИ  
HARDIK H. JARDOSH и MANISH P. PATEL 
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar-388120, Gujarat, India 
Синтетисана је серија од 24 деривата тетрахидрохиназолинона циклокондензацио-
ном реакцијом N-aлилхинолона, цикличног β-дикетона и (тио)урее/N-фенилтиоурее у 
присуству  лантан-трифлата  као  катализатора.  Примењена  методологија  омогућава 
добијање производа у високом приносу. Сви добијени производи тестирани су према 
репрезентативном  панелу  патогена,  а  in vitro  антимикробне  активности  одређене  су 
применом метода микроразблаживања и изражене као MIC (минимална инхибиторна 
концентрација). Утврђено је да седам деривата, 5h, 6b, 6h, 5f, 5l, 5n и 6g, има запажене 
активности. 
(Примљен 21. јануара, ревидиран 27. марта 2012) 
REFERENCES 
1.  O. I. El-Sabbagh, M. A. Shabaan, H. H. Kadry, E. S. Al-Din, Eur. J. Med. Chem. 45 (2010) 
5390 
2.  a) A. B. A. El-Gazzar, H. N. Hafez, H. S. Abbas, Eur. J. Med. Chem. 44 (2009) 4249; b) B. 
A. Rather, T. Raj, A. Reddy, M. S. Ishar, S. Sivakumar, P. Paneerselvam, Arch. Pharm. 
Chem. Life Sci. 343 (2010) 108 
3.  M. Yarim, S. Sarac, F. S. Kilic, K. Erol, Farmaco 58 (2003) 17 
4.  V. Jatav, P. Mishra, S. Kashaw, J. P. Stables, Eur. J. Med. Chem. 43 (2008) 135 
5.  M. Minu, A. Thangadurai, S. R. Wakode, S. S. Agrawal, B. Narasimhan, Arch. Pharm. 
Chem. Life Sci. 341 (2008) 231 
6.  G. Y. Lesher, E. J. Froelich, M. D. Gruett, J. H. Bailey, R. P. Brundage, J. Med. Pharm. 
Chem. 5 (1962) 1063 
7.  E. Filipponi, G. Cruciani, O. Tabarrini, V. Cecchetti, A. Fravolini, J. Comput.-Aided Mol. 
Des. 15 (2001) 203 
8.  J. Li, J. Tan, L. Chen, J. Zhang, X. Shen, C. Mei, L. Fu, L. Lin, J. Ding, B. Xiong, X. Xiong, 
H. Liu, X. Luo, H. Jiang, Acta Pharmacol. Sin. 27 (2006) 1259 
9.  R. Schaumann, A. C. Rodloff, Anti-Infect. Agents Med. Chem. 6 (2007) 49 
10.  F. O’Donnell, T. J. P. Smyth, V. N. Ramachandran, W. F. Smyth, Int. J. Antimicrob. Agents 
35 (2010) 30 
11.  V. Alptuzun, H. Tasli, E. Erciyas, J. Fac. Pharm, Ankara 35 (2006) 177 
12.  C. Praveen, A. Ayyanar, P. T. Perumal, Bioorg. Med. Chem. Lett. 21 (2011) 4072 
13.  a) N. N. Tonkikh, A. Strakovs, M. V. Petrova, Chem. Heterocycl. Compd. 40 (2004) 43; b) 
M. M. Candan, E. Kendi, M. Yarim, S. Sarac, M. Ertan, Anal. Sci. 17 (2001) 1023 
14.  S. Kantevari, R. Bantu, L. Nagarapu, ARKIVOC 2006 (2006) 136 
15.  M. A. Kolosov, V. D. Orlov, D. A. Beloborodov, V. V. Dotsenko, Mol. Divers. 13 (2009) 5 
16.  a) N. K. Shah, N. M. Shah, M. P. Patel, R. G. Patel, J. Serb. Chem. Soc. (2011), J. Serb. 
Chem. Soc. 77 (2012) 279; b) P. M. Shah, M. P. Patel, Med. Chem. Res. (2011), Med. Chem. 
Res. 21 (2012) 1188; c) D. C. Mungra, M. P. Patel, D. P. Rajani, R. G. Patel, Eur. J. Med. 
Chem. 46 (2011) 4192; d) N. J. Thumar, M. P. Patel, Arch. Pharm. Chem. Life Sci. 2 (2011) 
_____________________________________________________________________________________________________________________
2012 Copyright (CC) SCS
Available online at www.shd.org.rs/JSCS/1570  JARDOSH and PATEL 
91; e) H. G. Kathrotiya, R. G. Patel, M. P. Patel, J. Serb. Chem. Soc. (2011), J. Serb. Chem. 
Soc. 77 (2012) 983 
17.  National Committee for Clinical Laboratory Standards (NCCLS), Performance Standards 
for Antimicrobial Susceptibility Testing, Twelfth Informational Supplement (ISBN 1–
56238-454-6), 2002, M100-S12 (M7). 940, West Valley Road, Suite 1400, Wayne, PA, 
19087–1898, USA. 
18.  A. Srivastava, R. M. Singh, Indian J. Chem., B 44 (2005) 1868 
19.  a) R.-F. Chen, C.-T. Qian, Chin. J. Chem. 20 (2002) 427; b) L. Wang, C. Qian, H. Tian, Y. 
Ma, Synth. Commun. 33 (2003) 1459; c) C. Rui-Fang, Q. Chang-Tao, Chin. J. Chem. 20 
(2002) 407; d) A. Dondoni, A. Massi, S. Sabatini, Tetrahedron Lett. 43 (2002) 5913; e) D. 
Gong, L. Zhang, C. Yuan, Heteroatom Chem. 14 (2003) 13; f) Y. Huang, F. Yang, C. Zhu, 
J. Am. Chem. Soc. 127 (2005) 16386 
20.  I. Suzuki, Y. Suzumura, K. Takeda, Tetrahedron Lett. 47 (2006) 7861 
21.  Y. Ma, C. Qian, L. Wang, M. Yang, J. Org. Chem. 65 (2000) 3864. 
_____________________________________________________________________________________________________________________
2012 Copyright (CC) SCS
Available online at www.shd.org.rs/JSCS/